Sun L, Wang D M, Zhang W J, Zhang J, Wu J F
Department of Anatomy,Hebei North University, Zhangjiakou, 075000, China.
Department of Histology and Embryology, Hebei North University.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Jan 20;31(2):123-126. doi: 10.13201/j.issn.1001-1781.2017.02.010.
Experiments testing the concentration of serum E-cadherin were conducted through the patients with papillary thyroid carcinoma (PTC), nodular goiter and normal people. Combining the detection of E-cadherin protein in the tissues including papillary thyroid carcinoma,nodular goiter and normal thyroid tissues around adenoma,we analyze the effect and siginificance of E-cadherin in the papillary thyroid carcinoma.The concentrations of E-cadherin in the serum of 86 cases of PTC patients, 16 cases of NG patients and 10 normal adults were detected by enzyme linked immunosorbent assay (ELISA) method, and the relationships between the serum level and clinical pathology characteristics of thyroid papillary carcinoma were explored. Western blot were used to detect the content of E-cadherin protein in tissues including PTC, nodular goiter tissues and normal thyroid tissues around adenoma.The results showed that content of serum E-cadherin in PTC were significantly higher than those in nodular goiter tissues and normal thyroid issues (< 0.05). There were no obviously differences between nodular goiter tissues and normal thyroid issues in the content of E-cadherin (> 0.05). The content of E-cadherin protein in the tissues of PTC was evidently lower than those in nodular goiter tissues and normal thyroid tissues around adenoma (< 0.05). There were no obviously differences between nodular goiter tissues and normal thyroid tissues around adenoma in the content of E-cadherin (> 0.05). The abnormal expression of serum E-cadherin was correlated with the lymph node metastasis and pathological stage of PTC (< 0.05). On the other hand,it is irrelevant to the gender、age and the tumor size of the patients (> 0.05).The up-regulation of serum E-cadherin is correlated with the lymph node metastasis and pathological stage of PTC. The detection of the serum E-cadherin content plays a vital role in the aspects of early diagnosis and prognosis evaluation.
对甲状腺乳头状癌(PTC)患者、结节性甲状腺肿患者及正常人进行了血清E-钙黏蛋白浓度检测实验。结合对甲状腺乳头状癌、结节性甲状腺肿及腺瘤周围正常甲状腺组织中E-钙黏蛋白蛋白的检测,分析E-钙黏蛋白在甲状腺乳头状癌中的作用及意义。采用酶联免疫吸附测定(ELISA)法检测86例PTC患者、16例结节性甲状腺肿(NG)患者及10例正常成年人血清中E-钙黏蛋白的浓度,并探讨血清水平与甲状腺乳头状癌临床病理特征之间的关系。采用蛋白质免疫印迹法检测PTC组织、结节性甲状腺肿组织及腺瘤周围正常甲状腺组织中E-钙黏蛋白蛋白的含量。结果显示,PTC患者血清E-钙黏蛋白含量显著高于结节性甲状腺肿组织及正常甲状腺组织(<0.05)。结节性甲状腺肿组织与正常甲状腺组织中E-钙黏蛋白含量无明显差异(>0.05)。PTC组织中E-钙黏蛋白蛋白含量明显低于结节性甲状腺肿组织及腺瘤周围正常甲状腺组织(<0.05)。结节性甲状腺肿组织与腺瘤周围正常甲状腺组织中E-钙黏蛋白含量无明显差异(>0.05)。血清E-钙黏蛋白异常表达与PTC的淋巴结转移及病理分期相关(<0.05)。另一方面,与患者的性别、年龄及肿瘤大小无关(>0.05)。血清E-钙黏蛋白上调与PTC的淋巴结转移及病理分期相关。血清E-钙黏蛋白含量检测在早期诊断及预后评估方面具有重要作用。